Published in PLoS Genet on December 29, 2011
Aggregation of polyQ-extended proteins is promoted by interaction with their natural coiled-coil partners. Bioessays (2013) 1.48
Network organization of the huntingtin proteomic interactome in mammalian brain. Neuron (2012) 1.38
A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease. Cell Rep (2014) 1.17
Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation. Proc Natl Acad Sci U S A (2012) 1.14
Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs). Chem Rev (2014) 1.10
Identification of a tissue-selective heat shock response regulatory network. PLoS Genet (2013) 1.07
Prion-like proteins sequester and suppress the toxicity of huntingtin exon 1. Proc Natl Acad Sci U S A (2014) 0.98
Large-scale functional RNAi screen in C. elegans identifies genes that regulate the dysfunction of mutant polyglutamine neurons. BMC Genomics (2012) 0.96
Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in protein-misfolding diseases. Dis Model Mech (2014) 0.92
Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases. Antioxid Redox Signal (2013) 0.90
Track-a-worm, an open-source system for quantitative assessment of C. elegans locomotory and bending behavior. PLoS One (2013) 0.90
Alzheimer's disease-causing proline substitutions lead to presenilin 1 aggregation and malfunction. EMBO J (2015) 0.88
Aggregation of polyQ proteins is increased upon yeast aging and affected by Sir2 and Hsf1: novel quantitative biochemical and microscopic assays. PLoS One (2012) 0.87
Depletion of the C. elegans NAC engages the unfolded protein response, resulting in increased chaperone expression and apoptosis. PLoS One (2012) 0.86
Large-scale screen for modifiers of ataxin-3-derived polyglutamine-induced toxicity in Drosophila. PLoS One (2012) 0.85
Natural genetic variation determines susceptibility to aggregation or toxicity in a C. elegans model for polyglutamine disease. BMC Biol (2013) 0.84
Dynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo. J Biol Chem (2012) 0.84
Establishing a novel C. elegans model to investigate the role of autophagy in amyotrophic lateral sclerosis. Acta Pharmacol Sin (2013) 0.83
A genome-wide RNAi screen identifies potential drug targets in a C. elegans model of α1-antitrypsin deficiency. Hum Mol Genet (2014) 0.81
Hypoxia disrupts proteostasis in Caenorhabditis elegans. Aging Cell (2014) 0.81
Neuronal reprograming of protein homeostasis by calcium-dependent regulation of the heat shock response. PLoS Genet (2013) 0.80
O-GlcNAc cycling shows neuroprotective potential in C. elegans models of neurodegenerative disease. Worm (2013) 0.80
Novel polyglutamine model uncouples proteotoxicity from aging. PLoS One (2014) 0.80
The struggle by Caenorhabditis elegans to maintain proteostasis during aging and disease. Biol Direct (2016) 0.80
Using Caenorhabditis elegans as a model system to study protein homeostasis in a multicellular organism. J Vis Exp (2013) 0.79
Large-scale RNA interference screening in mammalian cells identifies novel regulators of mutant huntingtin aggregation. PLoS One (2014) 0.79
Studying polyglutamine aggregation in Caenorhabditis elegans using an analytical ultracentrifuge equipped with fluorescence detection. Protein Sci (2015) 0.77
Regulation of protein homeostasis in neurodegenerative diseases: the role of coding and non-coding genes. Cell Mol Life Sci (2015) 0.77
A genetic screen identifies Tor as an interactor of VAPB in a Drosophila model of amyotrophic lateral sclerosis. Biol Open (2014) 0.77
Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity. Dis Model Mech (2016) 0.76
Experimental models for identifying modifiers of polyglutamine-induced aggregation and neurodegeneration. Neurotherapeutics (2013) 0.76
A novel small molecule that disrupts a key event during the oocyte-to-embryo transition in C. elegans. Development (2016) 0.75
Identification of an RNA Polymerase III Regulator Linked to Disease-Associated Protein Aggregation. Mol Cell (2017) 0.75
Shaping proteostasis at the cellular, tissue, and organismal level. J Cell Biol (2017) 0.75
A network approach to discerning the identities of C. elegans in a free moving population. Sci Rep (2016) 0.75
Transcriptionally regulated cell adhesion network dictates distal tip cell directionality. Dev Dyn (2014) 0.75
Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency. PLoS One (2015) 0.75
In vivo properties of the disaggregase function of J-proteins and Hsc70 in Caenorhabditis elegans stress and aging. Aging Cell (2017) 0.75
The genetics of Caenorhabditis elegans. Genetics (1974) 102.14
Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature (2003) 26.58
Adapting proteostasis for disease intervention. Science (2008) 13.22
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature (2004) 11.82
High mobility of proteins in the mammalian cell nucleus. Nature (2000) 9.39
Genome-wide RNAi screening in Caenorhabditis elegans. Methods (2003) 7.83
A Drosophila model of Parkinson's disease. Nature (2000) 7.82
Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell (1998) 7.13
Rates of behavior and aging specified by mitochondrial function during development. Science (2002) 6.28
A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet (2002) 6.26
Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev (2008) 6.18
The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell (2011) 6.05
Opposing activities protect against age-onset proteotoxicity. Science (2006) 5.85
Toxic proteins in neurodegenerative disease. Science (2002) 5.82
Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell (2007) 5.51
Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science (2006) 5.39
Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem (2009) 5.23
Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell (2006) 5.01
Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol (1999) 4.98
Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci (2003) 4.75
Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci (1999) 4.27
The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2002) 4.25
Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell (1998) 4.07
Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell (2011) 3.98
Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J Neurosci Res (2002) 3.79
A systematic RNAi screen for longevity genes in C. elegans. Genes Dev (2005) 3.78
Relationship between mitochondrial electron transport chain dysfunction, development, and life extension in Caenorhabditis elegans. PLoS Biol (2007) 3.61
Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci U S A (2009) 3.44
Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci U S A (2000) 3.43
Genetic suppression of polyglutamine toxicity in Drosophila. Science (2000) 3.23
Opinion: What is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol (2005) 3.18
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science (2003) 2.89
Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci U S A (2004) 2.89
Molecular chaperone machines: chaperone activities of the cyclophilin Cyp-40 and the steroid aporeceptor-associated protein p23. Science (1996) 2.84
Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol (2009) 2.77
Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer. Nat Struct Mol Biol (2004) 2.50
A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nat Genet (2005) 2.28
Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology (2006) 2.27
Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet (2001) 2.13
Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models. EMBO J (2009) 2.09
C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet (2008) 2.03
Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci U S A (2003) 1.90
Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro. J Biol Chem (2006) 1.86
Genome-wide RNAi screening identifies protein damage as a regulator of osmoprotective gene expression. Proc Natl Acad Sci U S A (2006) 1.85
Protein homeostasis and aging: taking care of proteins from the cradle to the grave. J Gerontol A Biol Sci Med Sci (2009) 1.84
Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci U S A (1999) 1.84
Protein misfolding and neurodegeneration. Arch Neurol (2008) 1.78
The lipid binding pleckstrin homology domain in UNC-104 kinesin is necessary for synaptic vesicle transport in Caenorhabditis elegans. Mol Biol Cell (2004) 1.76
Identification and characterization of novel nicotinic receptor-associated proteins in Caenorhabditis elegans. EMBO J (2005) 1.73
Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet (2007) 1.66
Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J Neurosci (2006) 1.65
Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity. Proc Natl Acad Sci U S A (2002) 1.65
Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo. J Biol Chem (2010) 1.62
Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim Biophys Acta (2004) 1.60
Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet (2009) 1.56
Dietary factors, hormesis and health. Ageing Res Rev (2007) 1.50
Neuronal signaling modulates protein homeostasis in Caenorhabditis elegans post-synaptic muscle cells. Genes Dev (2007) 1.43
An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet (2009) 1.42
Bag1 functions in vivo as a negative regulator of Hsp70 chaperone activity. Mol Cell Biol (2000) 1.41
Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Hum Mol Genet (2005) 1.40
A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics (2010) 1.32
Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis. J Neurosci (2010) 1.25
Single charge change on the helical surface of the paramyosin rod dramatically disrupts thick filament assembly in Caenorhabditis elegans. J Mol Biol (1991) 1.25
Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment. Proc Natl Acad Sci U S A (2002) 1.24
Polyglutamine diseases: protein cleavage and aggregation. Curr Opin Neurobiol (1999) 1.23
A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J Biol Chem (2008) 1.23
Molecular mechanisms and treatment options for muscle wasting diseases. Annu Rev Pharmacol Toxicol (2011) 1.21
Ageing and the regulation of protein synthesis: a balancing act? Trends Cell Biol (2008) 1.19
Amyloid deposits: protection against toxic protein species? Cell Cycle (2009) 1.18
A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr Opin Struct Biol (2010) 1.13
Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans. Hum Mol Genet (2006) 1.10
Genetic defects in acetylcholine signalling promote protein degradation in muscle cells of Caenorhabditis elegans. J Cell Sci (2000) 1.05
Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms. EMBO Mol Med (2009) 1.00
Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways. Hum Mol Genet (2011) 1.00
Detection of polyglutamine protein oligomers in cells by fluorescence correlation spectroscopy. J Biol Chem (2007) 0.98
Selective degeneration in YAC mouse models of Huntington disease. Brain Res Bull (2006) 0.93
Molecular genetics approaches in yeast to study amyloid diseases. J Mol Neurosci (2004) 0.85
Adapting proteostasis for disease intervention. Science (2008) 13.22
Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science (2006) 5.39
Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem (2009) 5.23
Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science (2009) 4.80
Heat shock factors: integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol (2010) 4.63
Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol Biol Cell (2003) 4.63
Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. JAMA (2002) 4.36
The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2002) 4.25
Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci U S A (2009) 3.44
Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem (2005) 2.95
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet (2013) 2.91
Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci U S A (2004) 2.89
Regulation of the cellular heat shock response in Caenorhabditis elegans by thermosensory neurons. Science (2008) 2.59
Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. J Cell Sci (2002) 2.58
Molecular chaperones and the stress of oncogenesis. Oncogene (2004) 2.51
Celastrols as inducers of the heat shock response and cytoprotection. J Biol Chem (2004) 2.45
Transcription-dependent spatial arrangements of CFTR and adjacent genes in human cell nuclei. J Cell Biol (2004) 2.43
Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nat Cell Biol (2006) 2.37
Inefficient degradation of truncated polyglutamine proteins by the proteasome. EMBO J (2004) 2.24
Polyglutamine protein aggregates are dynamic. Nat Cell Biol (2002) 2.21
Bilateral pallidal stimulation for Wilson's disease. Mov Disord (2013) 1.98
Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation. Chem Biol (2008) 1.97
The biology of proteostasis in aging and disease. Annu Rev Biochem (2015) 1.96
Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem (2006) 1.91
Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J Cell Biol (2005) 1.74
Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule. Mol Biol Cell (2008) 1.69
Regulation of organismal proteostasis by transcellular chaperone signaling. Cell (2013) 1.66
Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J Neurosci (2006) 1.65
Small-molecule proteostasis regulators for protein conformational diseases. Nat Chem Biol (2011) 1.64
Metazoan Hsp70 machines use Hsp110 to power protein disaggregation. EMBO J (2012) 1.62
In vivo binding of active heat shock transcription factor 1 to human chromosome 9 heterochromatin during stress. J Cell Biol (2002) 1.59
Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin. Mol Cell Biol (2005) 1.58
Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet (2009) 1.56
Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms. Proc Natl Acad Sci U S A (2006) 1.56
Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry (2012) 1.54
Caenorhabditis elegans OSR-1 regulates behavioral and physiological responses to hyperosmotic environments. Genetics (2004) 1.49
The stress of protein misfolding: from single cells to multicellular organisms. Cold Spring Harb Perspect Biol (2011) 1.48
Protein homeostasis in models of aging and age-related conformational disease. Adv Exp Med Biol (2010) 1.48
Malfolded protein structure and proteostasis in lung diseases. Am J Respir Crit Care Med (2014) 1.47
Neuronal circuitry regulates the response of Caenorhabditis elegans to misfolded proteins. Proc Natl Acad Sci U S A (2011) 1.46
Huntingtin and mutant SOD1 form aggregate structures with distinct molecular properties in human cells. J Biol Chem (2005) 1.46
Neuronal signaling modulates protein homeostasis in Caenorhabditis elegans post-synaptic muscle cells. Genes Dev (2007) 1.43
Chaperone networks: tipping the balance in protein folding diseases. Neurobiol Dis (2010) 1.42
The nascent polypeptide-associated complex is a key regulator of proteostasis. EMBO J (2013) 1.40
Integrating the stress response: lessons for neurodegenerative diseases from C. elegans. Trends Cell Biol (2008) 1.36
Inhibition of translation and induction of apoptosis by Bunyaviral nonstructural proteins bearing sequence similarity to reaper. Mol Biol Cell (2003) 1.32
Huntington's disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci (2013) 1.31
The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70. Biochem J (2002) 1.31
The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging. Adv Exp Med Biol (2007) 1.30
Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. Am J Respir Cell Mol Biol (2002) 1.26
Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosis. J Med Chem (2011) 1.22
Proteomic analysis of nasal cells from cystic fibrosis patients and non-cystic fibrosis control individuals: search for novel biomarkers of cystic fibrosis lung disease. Proteomics (2006) 1.21
Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins. Cell Rep (2013) 1.20
Chimeric constructs endow the human CFTR Cl- channel with the gating behavior of murine CFTR. Proc Natl Acad Sci U S A (2007) 1.17
Modeling polyglutamine pathogenesis in C. elegans. Methods Enzymol (2006) 1.15
Canadian Guidelines on Parkinson's Disease. Can J Neurol Sci (2012) 1.15
Mathematical modeling of the eukaryotic heat-shock response: dynamics of the hsp70 promoter. Biophys J (2004) 1.15
A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr Opin Struct Biol (2010) 1.13
Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2010) 1.12
Protein homeostasis as a therapeutic target for diseases of protein conformation. Curr Top Med Chem (2012) 1.10
Elevated CO2 levels affect development, motility, and fertility and extend life span in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2009) 1.08
Structure-function analysis of the heat shock factor-binding protein reveals a protein composed solely of a highly conserved and dynamic coiled-coil trimerization domain. J Biol Chem (2001) 1.08
Identification of a tissue-selective heat shock response regulatory network. PLoS Genet (2013) 1.07
Antibodies for CFTR studies. J Cyst Fibros (2004) 1.06
Disease-modifying pathways in neurodegeneration. J Neurosci (2006) 1.06
Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition. Proc Natl Acad Sci U S A (2014) 1.05
CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis. Gastroenterology (2004) 1.04
Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation. Hum Mol Genet (2007) 1.03
Caregiving by family and friends of adults receiving dialysis. Nephrol Nurs J (2006) 1.02
Spreading of a prion domain from cell-to-cell by vesicular transport in Caenorhabditis elegans. PLoS Genet (2013) 1.00
Measuring mild cognitive impairment in patients with Parkinson's disease. Mov Disord (2013) 1.00
Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways. Hum Mol Genet (2011) 1.00
Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR. J Physiol (2014) 1.00
Biochemical methods to assess CFTR expression and membrane localization. J Cyst Fibros (2004) 1.00
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis. Bioorg Med Chem (2010) 0.99
AMPK controls epithelial Na(+) channels through Nedd4-2 and causes an epithelial phenotype when mutated. Pflugers Arch (2009) 0.97
Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi. FEBS J (2013) 0.96
Regulation of the epithelial Na+ channel by the protein kinase CK2. J Biol Chem (2008) 0.95
Unusually common cystic fibrosis mutation in Portugal encodes a misprocessed protein. Biochem Biophys Res Commun (2003) 0.94
Revertants, low temperature, and correctors reveal the mechanism of F508del-CFTR rescue by VX-809 and suggest multiple agents for full correction. Chem Biol (2013) 0.93
Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in protein-misfolding diseases. Dis Model Mech (2014) 0.92
The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients. PLoS One (2011) 0.92
A comparison of 14 antibodies for the biochemical detection of the cystic fibrosis transmembrane conductance regulator protein. Mol Cell Probes (2004) 0.92
Measurements of CFTR-mediated Cl- secretion in human rectal biopsies constitute a robust biomarker for Cystic Fibrosis diagnosis and prognosis. PLoS One (2012) 0.92
Characterization of novel airway submucosal gland cell models for cystic fibrosis studies. Cell Physiol Biochem (2005) 0.91
Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experience. J Interv Cardiol (2002) 0.91
Heat shock response activation exacerbates inclusion body formation in a cellular model of Huntington disease. J Biol Chem (2013) 0.91
Experimental assessment of splicing variants using expression minigenes and comparison with in silico predictions. Hum Mutat (2014) 0.90
Associated movement disorders in orthostatic tremor. J Neurol Neurosurg Psychiatry (2012) 0.90
Deletion of CFTR translation start site reveals functional isoforms of the protein in CF patients. Cell Physiol Biochem (2009) 0.90
Celastrol analogues as inducers of the heat shock response. Design and synthesis of affinity probes for the identification of protein targets. ACS Chem Biol (2012) 0.90
Caenorhabditis elegans as a model system to study intercompartmental proteostasis: Interrelation of mitochondrial function, longevity, and neurodegenerative diseases. Dev Dyn (2010) 0.90
CFTR localization in native airway cells and cell lines expressing wild-type or F508del-CFTR by a panel of different antibodies. J Histochem Cytochem (2004) 0.90
Methods for RNA extraction, cDNA preparation and analysis of CFTR transcripts. J Cyst Fibros (2004) 0.89
In vivo translation rates can substantially delay the cotranslational folding of the Escherichia coli cytosolic proteome. Proc Natl Acad Sci U S A (2012) 0.89
HGF stimulation of Rac1 signaling enhances pharmacological correction of the most prevalent cystic fibrosis mutant F508del-CFTR. ACS Chem Biol (2012) 0.89
l-Dopa-induced dyskinesia-clinical presentation, genetics, and treatment. Int Rev Neurobiol (2011) 0.89
Macro-level modeling of the response of C. elegans reproduction to chronic heat stress. PLoS Comput Biol (2012) 0.88